Oncopod
Contact Us
Oncopod
Menu

Fulphila™
(FULL-fil-ah)
(pegfilgrastim-jmdb)

Chemotherapy 

Have a Question ?

Fulphila™
(FULL-fil-ah)
(pegfilgrastim-jmdb)

Chemotherapy

Have a Question ?

What is Fulphila?

Fulphila is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood cell important in the body’s fight against infection.

What is the most important information I should know about Fulphila?

Fulphila can cause serious side effects. These serious side effects include:

  • Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or your left shoulder.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency care right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious allergic reactions. Fulphila can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using Fulphila and call your healthcare provider or get emergency medical help right away.
  • Sickle cell crises. You may have a serious sickle cell crisis if you have a sickle cell disorder and receive Fulphila. Serious sickle cell crises have happened in people with sickle cell disorders receiving Fulphila that has sometimes led to death. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing.
  • Kidney injury (glomerulonephritis). Fulphila can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms:
  • swelling of your face or ankles
  • blood in your urine or dark colored urine
  • you urinate less than usual
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with Fulphila.
  • Capillary Leak Syndrome. Fulphila can cause fluid to leak from blood vessels into your body’s tissues. This condition is called “Capillary Leak Syndrome” (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:
  • swelling or puffiness and are urinating less than usual
  • trouble breathing
  • swelling of your stomach-area (abdomen) and feeling of fullness
  • dizziness or feeling faint
  • a general feeling of tiredness
  • The most common side effects of Fulphila are pain in the bones, arms, and legs.

These are not all the possible side effects of Fulphila. Call your doctor for medical advice about side effects.

How will I receive Fulphila?

  • Fulphila is given as an injection under your skin (subcutaneous injection) by a healthcare provider. If your healthcare provider decides that the subcutaneous injections can be given at home by you or your caregiver, follow the detailed “Instructions for Use” that comes with your Fulphila for information on how to prepare and inject a dose of Fulphila.
  • You and your caregiver will be shown how to prepare and inject Fulphila before you use it.
  • You should not inject a dose of Fulphila to children weighing less than 45 kg from a Fulphila prefilled syringe. A dose less than 0.6 mL (6 mg) cannot be accurately measured using the Fulphila prefilled syringe.
  • If you are receiving Fulphila because you are also receiving chemotherapy, the last dose of Fulphila should be injected at least 14 days before and 24 hours after your dose of chemotherapy.
  • If you miss a dose of Fulphila, talk to your healthcare provider about when you should give your next dose.

Insert text here

 

Nucleic Acid Diagnostic kit

Important Safety Information

  • Do not take Fulphila if you have had a serious allergic reaction to pegfilgrastim or filgrastim products.
  • It is not known if Fulphila will harm your unborn baby.
  • It is not known if pegfilgrastim passes into your breast milk.

Ask your healthcare provider if you do not know.

What should I tell my healthcare provider before taking Fulphila?

Before you receive Fulphila, tell your healthcare provider about all of your medical conditions, including if you:

  • have a sickle cell disorder.
  • have kidney problems
  • are pregnant or plan to become pregnant. It is not known if Fulphila will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if pegfilgrastim passes into your breast milk.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Available 24/7
Experiencing
symotoms that
concern you
Chat Online Now

General information about Fulphila

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use Fulphila for a condition for which it was not prescribed. Do not give Fulphila to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about Fulphila that is written for health professionals.

What are the ingredients in Fulphila?

Active ingredient: pegfilgrastim-jmdb

Inactive ingredient: acetate, D-sorbitol, polysorbate 20, and sodium in Water for Injection

This Patient Information has been approved by the U.S. Food and Drug Administration.

Please see full Prescribing Information for additional Important Safety Information.

Have questions about chemotherapy?

Contact for Second Opinion or Free Counselling

+91-882-688-3200
Available 24/7
Experiencing
symotoms that
concern you
Chat Online Now
Have questions
about cancer?
Just ask Alexa. Find voice-activated answers to 800+ questions on 40+ cancer types.
Learn How